Eigencluster: Presentation 1 notes


 * Advisory Committee
 * Get the official titles of Jon Kaufman and Ira Haimowitz (CSO)


 * Bioinformatics industry
 * why is it important that the info generated by biotech industry doubles every 6 months?
 * emphasize that if pharma has better data analysis, they can speed up drug trials by 33%
 * Who are the lead players and how much do they have?


 * Clustering algorithms
 * What algorithms do our competitors use? This may be hard to find, but we should try.


 * Niche opportunities
 * What part of the biotech market is SNP analysis software?
 * Why did we choose biotech?


 * Customers
 * Who are our gold buyers?
 * Who are our first buyers? Academics?
 * Talk to potential buyers
 * How do they decide if it's worth doing a trial?
 * How do they go about buying a product? Do they have any regrets about their current products?
 * How often do they get servicing?
 * Problems with big pharma
 * It may take them a year longer to decide if they will use our product. What do we do in this case?
 * Accreditation time?
 * We might want to increase service fee so get more $$. Many companies make the bulk of their money through service.
 * To what extent is habit important?
 * Recent NCI/Illumina contract
 * How was this brokered?
 * How did the timing of sales work?
 * Was there a trial basis over which they look at several products and choose one?


 * IP info
 * What is the track record of the inventor?
 * Is the product patented yet?
 * How many patents have been filed in this field in the past few years?


 * Why not keep our algorithm to ourselves?
 * How much money do we want right now?
 * Financial projection
 * Bear in mind that revenue must be divided among 12 months. Sales in Q3 and Q4 only count 50% and 25% of sales.